Recently, we showed that the metabolic enzyme phosphoenolpyruvate carboxykinase (PEPCK; HUGO: PCK1) increases colon cancer cell growth in part by promoting the use of both glucose and glutamine by the TCA cycle [20]. The gene discussed is PCK2; the disease is colonic neoplasm.